C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
167/103.05, 195/
C12N 15/12 (2006.01) A61K 38/17 (2006.01) C07K 14/05 (2006.01) C07K 14/705 (2006.01) C12N 5/10 (2006.01) C12N 15/63 (2006.01) A61K 38/00 (2006.01)
Patent
CA 1340866
The present invention relates to the C3b/C4b receptor (CR1) gene and its encoded protein. The invention also relates to CR1 nucleic acid sequences and fragments thereof comprising 70 nucleotides and their encoded peptides or proteins comprising 24 amino acids. The invention further provides for the expression of the CR1 protein and fragments thereof. The genes and proteins of the invention have uses in diagnosis and therapy of disorders involving complement activity, and various immune system or inflammatory disorders. In specific embodiments of the present invention detailed in the examples sections infra, the cloning, nucleotide sequence, and deduced amino acid sequence of a full-length CR1 cDNA and fragments thereof are described. The expression of the CR1 protein and fragments thereof is also described. Also described is the expression of a secreted CR1 molecule lacking a transmembrane region. The secreted CR1 molecule is shown to be useful in reducing damage caused by inflammation and in reducing myocardial infarct size and preventing reperfusion injury.
595389
Carson Gerald R.
Concino Michael F.
Fearon Douglas T.
Ip Stephen H.
Klickstein Lloyd B.
Brigham And Women's Hospital Inc.
Carson Gerald R.
Celldex Therapeutics Inc.
Concino Michael F.
Fearon Douglas T.
LandOfFree
Human c3b/c4b receptor (cr1) does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Human c3b/c4b receptor (cr1), we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human c3b/c4b receptor (cr1) will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1221420